Is Cytosorbents Corp (CTSO) Halal?
Shariah Screening — 5 Standards
Based on financial data from December 2024
| Standard | Debt Ratio | Cash Ratio | Receivables | Income | Status |
|---|---|---|---|---|---|
| AAOIFI | 53.7% / 30% | 6.5% / 30% | 14.6% / 30% | 11.87% / 5% | ✗ NOT HALAL |
| DJIM | 53.7% / 33% | 6.5% / 33% | 14.6% / 33% | 11.87% / 5% | ✗ NOT HALAL |
| MSCI | 56.8% / 33% | 6.9% / 33% | 15.5% / 33% | 11.87% / 5% | ✗ NOT HALAL |
| S&P | 53.7% / 33% | 6.5% / 33% | 14.6% / 33% | 11.87% / 5% | ✗ NOT HALAL |
| FTSE | 56.8% / 33% | 6.9% / 33% | 15.5% / 50% | 11.87% / 5% | ✗ NOT HALAL |
Financial Highlights
Profitability
| Gross Margin | 71.5% | |
| Operating Margin | -43.9% | |
| Net Margin | -22.1% | |
| Return on Equity (ROE) | -96.4% | |
| Return on Assets (ROA) | -19.4% |
Cash Flow & Balance Sheet
| Operating Cash Flow | -$14M |
| Free Cash Flow | -$15M |
| Total Debt | $27M |
| Debt-to-Equity | 493.2 |
| Current Ratio | 2.1 |
| Total Assets | $47M |
Price & Trading
| Last Close | $0.60 |
| 50-Day MA | $0.69 |
| 200-Day MA | $0.84 |
| Avg Volume | 86K |
| Beta | 1.4 |
|
52-Week Range
$0.50
| |
About Cytosorbents Corp (CTSO)
Cytosorbents Corporation engages in the research, development, and commercialization of medical devices with its blood purification technology platform incorporating a proprietary adsorbent and porous polymer technology in the United States, Germany, and internationally. The company's flagship product is CytoSorb, an extracorporeal blood purification cartridge for the treatment of massive inflammation, organ failure, cardiothoracic surgery to remove antithrombotic drugs and inflammatory mediators that can lead to postoperative complications, such as severe bleeding, shock, failure to wean from mechanical ventilation, sepsis, and multiple organ failure; DrugSorb-ATR, an antithrombotic removal system; VetResQ, a broad-spectrum blood purification adsorber for the treatment of septic shock, toxic shock syndrome, toxin-mediated diseases, pancreatitis, trauma, liver failure, heat stroke, and lung injury in animals; PuriFi, an advanced hemoperfusion pump for blood purification therapies; and ECOS-300CY, an ex vivo organ perfusion system to preserve or improve the health and quality of harvested solid organs to be transplanted. In addition, it develops HemoDefend-BGA, a blood purification technology platform to reduce anti-A and anti-B antibodies in plasma and whole blood. The company was formerly known as MedaSorb Technologies Corporation and changed its name to Cytosorbents Corporation in May 2010. Cytosorbents Corporation was founded in 1997 and is headquartered in Princeton, New Jersey.
Related Halal Stocks in Healthcare
Frequently Asked Questions
Is Cytosorbents Corp (CTSO) halal to invest in?
Based on our screening using AAOIFI Standard 21 (the strictest methodology), Cytosorbents Corp is Not Halal. The company fails one or more screening criteria. We screen against all 5 major standards: AAOIFI, DJIM, MSCI, S&P, and FTSE.
What is Cytosorbents Corp's debt ratio?
Cytosorbents Corp's debt ratio is 53.7% under the AAOIFI standard (which uses market capitalization as the denominator). The AAOIFI threshold is 30%. Under MSCI and FTSE (which use total assets as the denominator), the debt ratio is 56.8%.
What are Cytosorbents Corp's key financial metrics?
Cytosorbents Corp has a market capitalization of $37M, and revenue of $36M. The company maintains a gross margin of 71.5% and a net margin of -22.1%. Return on equity stands at -96.4%.
How often is the screening data updated?
Our screening data is updated regularly using the latest available financial statements and market data. Stock prices and market caps are refreshed frequently, while financial statements are updated quarterly when companies report earnings.
Disclaimer: HalalStockGuide.com provides Shariah compliance screening for educational and informational purposes only. This is not a fatwa, financial advice, or a recommendation to buy or sell any security. Screening results are based on publicly available financial data and established methodologies. Always consult a qualified Islamic scholar and a licensed financial advisor before making investment decisions.